The FCR-1: Initial validation of a single-item measure of fear of cancer recurrence.
Psychooncology
; 29(4): 788-795, 2020 04.
Article
en En
| MEDLINE
| ID: mdl-32026563
ABSTRACT
OBJECTIVE:
Fear of cancer recurrence (FCR) is characterized by the fear, worry or concern that cancer will come back or progress. The negative effects associated with FCR are consistently identified by cancer survivors as one of their most prominent unmet needs. Current measures of FCR can be long, complex and burdensome for survivors to complete. The objective of the present study is to develop and validate a one-item measure of FCR.METHODS:
The ability of the FCR-1 to detect change in FCR over time was analyzed using a repeated-measures ANOVA and paired-samples t-tests. Pearson correlations were used to measure the concurrent, convergent and discriminant validity of the FCR-1, and a ROC analysis was conducted to determine an optimal clinical cut-off score.RESULTS:
The FCR-1 was found to be responsive to change in FCR over time. It demonstrated concurrent validity with the FCRI (r = .395, P = .010), and convergent validity with the Mishel Uncertainty in Illness Scale (r = .493, P = .001) and the Reassurance Questionnaire (r = .325, P = .044). Discriminant validity was confirmed when the FCR-1 did not significantly correlate with unrelated measures. A ROC analysis pinpointed an optimal clinical cut-off score of 45.0.CONCLUSIONS:
The FCR-1 is a promising tool that can be incorporated in clinical and research settings. Due to its brevity, the care needs of highly distressed patients can be met quickly and efficiently. In research settings, the FCR-1 can reduce the cognitive burden experienced by survivors.Palabras clave
Texto completo:
1
Colección:
01-internacional
Asunto principal:
Trastornos Fóbicos
/
Escalas de Valoración Psiquiátrica
/
Supervivientes de Cáncer
/
Distrés Psicológico
/
Recurrencia Local de Neoplasia
Tipo de estudio:
Prognostic_studies
/
Qualitative_research
Límite:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Psychooncology
Asunto de la revista:
NEOPLASIAS
/
PSICOLOGIA
Año:
2020
Tipo del documento:
Article
País de afiliación:
Canadá